NCT04429191
Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT04429191
Title JSP191 Antibody Targeting Conditioning in MDS/AML Patients Undergoing Hematopoietic Cell Transplantation
Recruitment Completed
Gender both
Phase Phase I
Variant Requirements No
Sponsors Jasper Therapeutics, Inc.
Indications
Therapies
Age Groups: adult | senior
Covered Countries USA

Facility Status City State Zip Country Details
City of Hope Comprehensive Cancer Center Duarte California 91010 United States Details
Stanford University Stanford California 94305 United States Details
Rush University Medical Center Chicago Illinois 60612 United States Details
Oregon Health & Science University Portland Oregon 97239 United States Details
Huntsman Cancer Institute - University of Utah Salt Lake City Utah 84112 United States Details
Fred Hutchinson Cancer Research Center Seattle Washington 98109 United States Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field